Effect of wound type on Smad 2 and 4 translocation

Investigative Ophthalmology and Visual Science

Volumn 46, Issue 7, 2005, Pages 2362-2368

  Hutcheon, Audrey E K ^a   Guo, Xiaoqing Q ^a   Stepp, Mary Ann ^b   Simon, Kenneth J ^c   Weinreb, Paul H ^c   Violette, Shelia M ^c   Zieske, James D ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c BIOGEN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ALPHAVBETA6 INTEGRIN; CANCER GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE P38; RECEPTOR; SMAD2 PROTEIN; SMAD4 PROTEIN; UNCLASSIFIED DRUG; 4-(4-FLUOROPHENYL)-2-(4-HYDROXYPHENYL)-5-(4-PYRIDYL)IMIDAZOLE; DNA BINDING PROTEIN; ENZYME INHIBITOR; IMIDAZOLE DERIVATIVE; INTEGRIN; MADH2 PROTEIN, RAT; MADH4 PROTEIN, RAT; PYRIDINE DERIVATIVE; SMAD2 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; TUMOR ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; CYTOPLASM; DEBRIDEMENT; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; KERATECTOMY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; WOUND; WOUND HEALING; ANIMAL; BASEMENT MEMBRANE; CELL MOTION; CORNEA EPITHELIUM; CULTURE TECHNIQUE; DRUG ANTAGONISM; DRUG EFFECT; INJURY; METABOLISM; ORGAN CULTURE TECHNIQUE; PHYSIOLOGY; PROTEIN TRANSPORT; SPRAGUE DAWLEY RAT; UPREGULATION;

ANIMALS; ANTIGENS, NEOPLASM; BASEMENT MEMBRANE; CELL CULTURE TECHNIQUES; CELL MOVEMENT; CYTOPLASM; DEBRIDEMENT; DNA-BINDING PROTEINS; ENZYME INHIBITORS; EPITHELIUM, CORNEAL; HUMANS; IMIDAZOLES; INTEGRINS; MALE; ORGAN CULTURE TECHNIQUES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN TRANSPORT; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; SMAD2 PROTEIN; SMAD4 PROTEIN; TRANS-ACTIVATORS; UP-REGULATION; WOUND HEALING;

EID: 23244465026     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.04-0759     Document Type: Article

References (43)

1. Zieske JD, Gipson IK. Agents that affect corneal wound healing: modulation of structure and function. In: Albert DM, Jakobiec FA, eds. Principles and Practice of Ophthalmology. Philadelphia: WB Saunders Company; 1994:1093-1099.
2. Zieske JD. Expression of cyclin-dependent kinase inhibitors during corneal wound repair. Prog Retin Eye Res. 2000;19:257-270.
3. Cotsarelis G, Cheng SZ, Dong G, Sun TT, Lavker RM. Existence of slow-cycling limbal epithelial basal cells that can be preferentially stimulated to proliferate: implications on epithelial stem cells. Cell. 1989;57:201-209.
4. Lavker RM, Dong G, Cheng SZ, Kudoh K, Cotsarelis G, Sun TT. Relative proliferative rates of limbal and corneal epithelia. Implications of corneal epithelial migration, circadian rhythm, and suprabasally located DNA-synthesizing keratinocytes. Invest Ophthalmol Vis Sci. 1991;32:1864-1875.
5. Zieske JD, Francesconi CM, Guo X. Cell cycle regulators at the ocular surface. Exp Eye Res. 2004;78:447-456.
6. Francesconi CM, Hutcheon AE, Chung EH, Dalbone AC, Joyce NC, Zieske JD. Expression patterns of retinoblastoma and E2F family proteins during corneal development. Invest Ophthalmol Vis Sci. 2000;41:1054-1062.
7. Chung EH, Hutcheon AE, Joyce NC, Zieske JD. Synchronization of the G1/S transition in response to corneal debridement. Invest Ophthalmol Vis Sci. 1999;40:1952-1958.
8. Haaskjold E, Sandvig KU, Bjerknes R, Kravik K. The early cell kinetic response during healing of corneal epithelial wounds. Ophthalmic Surg. 1992;23:680-684.
9. Sandvig KU, Haaskjold E, Bjerknes R, Refsum SB, Kravik K. Cell kinetics of conjunctival and corneal epithelium during regeneration of different-sized corneal epithelial defects. Acta Ophthalmol (Copenh). 1994;72:43-48.
10. Reed SI, Bailly E, Dulic V, Hengst L, Resnitzky D, Slingerland J. Gl control in mammalian cells. J Cell Sci Suppl. 1994;18:69-73.
11. Massague J. TGF-beta signal transduction. Annu Rev Biochem. 1998;67:753-791.
12. Massague J, Polyak K. Mammalian antiproliferative signals and their targets. Curr Opin Genet Dev. 1995;5:91-96.
13. Zieske JD, Hutcheon AE, Guo X, Chung EH, Joyce NC. TGF-beta receptor types I and II are differentially expressed during corneal epithelial wound repair. Invest Ophthalmol Vis Sci. 2001;42: 1465-1471.
14. Carnero A, Hannon GJ. The INK4 family of CDK inhibitors. Curr Top Microbiol Immunol. 1998;227:43-55.
15. Pavletich NP. Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors. J Mol Biol. 1999;287:821-828.
16. Roussel MF. The INK4 family of cell cycle inhibitors in cancer. Oncogene. 1999;18:5311-5317.
17. Seoane J, Pouponnot C, Staller P, Schader M, Eilers M, Massague J. TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b. Nat Cell Biol. 2001;3:400-408.
18. Sekelsky JJ, Newfeld SJ, Raftery LA, Chartoff EH, Gelbart WM. Genetic characterization and cloning of mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster. Genetics. 1995;139:1347-1358.
19. Savage C, Das P, Finelli AL, et al. Caenorhabditis elegans genes sma-2, sma-3, and sma-4 define a conserved family of transforming growth factor beta pathway components. Proc Natl Acad Sci USA. 1996;93:790-794.
20. Yu L, Hebert MC, Zhang YE. TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses. EMBO J. 2002;21:3749-3759.
21. Yamanaka O, Saika S, Okada Y, Ooshima A, Ohnishi Y. Effects of interferon-gamma on human subconjunctival fibroblasts in the presence of TGFbeta1: reversal of TGFbeta-stimulated collagen production. Graefes Arch Clin Exp Ophthalmol. 2003;241:116-124.
22. Flanders KC, Kim ES, Roberts AB. Immunohistochemical expression of Smads 1-6 in the 15-day gestation mouse embryo: signaling by BMPs and TGF-betas. Dev Dyn. 2001;220:141-154.
23. Attisano L, Tuen Lee-Hoeflich S. The Smads. Genome Biol. 2001; 2:Reviews3010.1-Reviews3010.8.
24. Verrecchia F, Mauviel A. Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation. J Invest Dermatol. 2002;118:211-215.
25. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 2003;425:577-584.
26. Massague J. How cells read TGF-beta signals. Nat Rev Mol Cell Biol. 2000;1:169-178.
27. Zieske JD, Chung EH, Guo X, Hutcheon AEK. Human corneal organotypic cultures. J Toxicol. 2004;23:37-46.
28. Weinreb PH, Simon KJ, Rayhorn P, et al. Function-blocking integrin alphavbeta6 monoclonal antibodies: distinct ligand-mimetic and nonligand-mimetic classes. J Biol Chem. 2004;279:17875-17887.
29. Zieske JD, Higashijima SC, Spurr-Michaud SJ, Gipson IK. Biosynthetic responses of the rabbit cornea to a keratectomy wound. Invest Ophthalmol Vis Sci. 1987;28:1668-1677.
30. Zieske JD, Gipson IK. Protein synthesis during corneal epithelial wound healing. Invest Ophthalmol Vis Sci. 1986;27:1-7.
31. Zieske JD, Wasson M. Regional variation in distribution of EGF receptor in developing and adult corneal epithelium. J Cell Sci. 1993;106:145-152.
32. Zieske JD, Bukusoglu G. Effect of protease inhibitors on corneal epithelial migration. Invest Ophthalmol Vis Sci. 1991;32:2073-2078.
33. Saika S, Okada Y, Miyamoto T, et al. Role of p38 MAP kinase in regulation of cell migration and proliferation in healing corneal epithelium. Invest Ophthalmol Vis Sci. 2004;45:100-109.
34. Munger JS, Huang X, Kawakatsu H, et al. The integral alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell. 1999;96:319-328.
35. Annes JP, Rifkin DB, Munger JS. The integrin alphaVbeta6 binds and activates latent TGFbeta3. FEBS Lett. 2002;511:65-68.
36. Zagon IS, Sassani JW, Ruth TB, McLaughlin PJ. Cellular dynamics of corneal wound re-epithelialization in the rat. III. Mitotic activity. Brain Res. 2000;882:169-179.
37. Sharma GD, He J, Bazan HE. p38 and ERK1/2 coordinate cellular migration and proliferation in epithelial wound healing: evidence of cross-talk activation between MAP kinase cascades. J Biol Chem. 2003;278:21989-21997.
38. Zieske JD, Takahashi H, Hutcheon AE, Dalbone AC. Activation of epidermal growth factor receptor during corneal epithelial migration. Invest Ophthalmol Vis Sci. 2000;41:1346-1355.
39. Sta Iglesia DD, Stepp MA. Disruption of the basement membrane after corneal debridement. Invest Ophthalmol Vis Sci. 2000;41: 1045-1053.
40. Feng XH, Lin X, Derynck R. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta. EMBO J. 2000;19:5178-5193.
41. Massague J. Integration of Smad and MAPK pathways: a link and a linker revisited. Genes Dev. 2003;17:2993-2997.
42. Stramer BM, Zieske JD, Jung JC, Austin JS, Fini ME. Molecular mechanisms controlling the fibrotic repair phenotype in cornea: implications for surgical outcomes. Invest Ophthalmol Vis Sci. 2003;44:4237-4246.
43. Kamaraju AK, Roberts AB. Role of Rho/ROCK and p38 MAP kinase pathways in transforming growth factor-β-mediated Smad-dependent growth inhibition of human breast carcinoma cells in vivo. J Biol Chem. 2005;280:1024-1036.